|
🦁
|
The role of kynurenines in disorders of the central nervous system: Possibilities for neuroprotection
E. Vámos,
Á. Párdutz,
P. Klivényi,
J. Toldi,
L. Vécsei
|
6 |
2009 |
6
🦁
|
|
🐬
|
Valproate ameliorates the survival and the motor performance in a transgenic mouse model of Huntington's disease
D. Zádori,
A. Geisz,
E. Vámos,
L. Vécsei,
P. Klivényi
|
6 |
2009 |
6
🐬
|
|
🐬
|
Kynurenines in chronic neurodegenerative disorders: future therapeutic strategies
D. Zádori,
P. Klivényi,
E. Vámos,
F. Fülöp,
J. Toldi,
László Vécsei
|
6 |
2009 |
6
🐬
|
|
🦁
|
l-kynurenine combined with probenecid and the novel synthetic kynurenic acid derivative attenuate nitroglycerin-induced nNOS in the rat caudal trigeminal nucleus
8 auth.
E. Vámos,
Á. Párdutz,
Hedvig Varga,
Zsuzsanna Bohár,
J. Tajti,
F. Fülöp,
...
J. Toldi,
L. Vécsei
|
6 |
2009 |
6
🦁
|
|
🐬
|
Effect of systemic kynurenine on cortical spreading depression and its modulation by sex hormones in rat
V. Chauvel,
E. Vámos,
Á. Párdutz,
L. Vécsei,
J. Schoenen,
S. Multon
|
5 |
2012 |
5
🐬
|
|
🐬
|
Syntheses, transformations and pharmaceutical applications of kynurenic acid derivatives.
F. Fülöp,
I. Szatmári,
E. Vámos,
D. Zádori,
J. Toldi,
L. Vécsei
|
5 |
2009 |
5
🐬
|
|
🦁
|
Kynurenate Derivative Attenuates the Nitroglycerin‐Induced CamKIIα and CGRP Expression Changes
8 auth.
E. Vámos,
Annamária Fejes,
J. Koch,
J. Tajti,
F. Fülöp,
J. Toldi,
...
Á. Párdutz,
L. Vécsei
|
5 |
2009 |
5
🦁
|
|
🐜
|
Migraine is a neuronal disease
9 auth.
J. Tajti,
Á. Párdutz,
E. Vámos,
Bernadett Tuka,
Anikó Kuris,
Zsuzsanna Bohár,
...
Annamária Fejes,
J. Toldi,
L. Vécsei
|
5 |
2011 |
5
🐜
|
|
🦁
|
Neuroprotective effects of L-carnitine in a transgenic animal model of Huntington's disease.
E. Vámos,
K. Voros,
L. Vécsei,
P. Klivényi
|
5 |
2010 |
5
🦁
|
